Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants
Public ClinicalTrials.gov record NCT02052310. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Efficacy and Safety of FG-4592 in the Treatment of Anemia in Incident-Dialysis Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether roxadustat is safe and effective in the treatment of anemia in participants who have just begun dialysis treatment for ESRD.
Study identification
- NCT ID
- NCT02052310
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,043 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2014 (Actual)
- Primary completion
- Sep 21, 2018 (Actual)
- Completion
- Sep 21, 2018 (Actual)
- Last update posted
- Oct 1, 2021
2014 – 2018
United States locations
- U.S. sites
- 30
- U.S. states
- 14
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Chula Vista | California | 91910 | — |
| Investigational Site | La Mesa | California | 91942 | — |
| Investigational Site | San Diego | California | 92111 | — |
| Investigational Site | Coral Springs | Florida | 33071 | — |
| Investigational Site | Lauderdale Lakes | Florida | 33313-1638 | — |
| Investigational Site | Miami | Florida | 33143 | — |
| Investigational Site | Miami | Florida | 33173 | — |
| Investigational Site | Tampa | Florida | 33614 | — |
| Meridian | Meridian | Idaho | 83642 | — |
| Investigational Site | Shreveport | Louisiana | 71101 | — |
| Investigational Site | Detroit | Michigan | 48236 | — |
| Investigational Site | Pontiac | Michigan | 48341 | — |
| Investigational Site | Brookhaven | Mississippi | 39601 | — |
| Investigational Site | Columbus | Mississippi | 39705 | — |
| Investigational Site | Gulfport | Mississippi | 39501 | — |
| Investigational Site | Tupelo | Mississippi | 38801 | — |
| Investigational Site | Saint Ann | Missouri | 63074 | — |
| Investigational Site | St Louis | Missouri | 63136 | — |
| Investigational Site | Portsmouth | New Hampshire | 38815 | — |
| Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Investigational Site | Durham | North Carolina | 27704 | — |
| Investigational Site | New Bern | North Carolina | 28562 | — |
| Investigational Site | Columbus | Ohio | 43215 | — |
| Investigational Site | Columbia | South Carolina | 29203 | — |
| Investigational Site | Orangeburg | South Carolina | 29118 | — |
| Investigational Site | Sumter | South Carolina | 29150 | — |
| Investigational Site | Knoxville | Tennessee | 37923 | — |
| Investigational Site | Edinburg | Texas | 78539 | — |
| Investigational Site | Houston | Texas | 77099 | — |
| Investigational Site | Houston | Texas | 77450 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02052310, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02052310 live on ClinicalTrials.gov.